Study finds major anti-inflammatory immune activity that favors oral cancer tumors
Time-dependent viral interference between influenza virus and coronavirus in the infection of differ
2 June 2021‘Prescription’ to sit less, move more advised for mildly high blood pressure and cholesterol
2 June 2021Study finds major anti-inflammatory immune activity that favors oral cancer tumors
A collaborative research led by immunologist Estefania Nova-Lamperti from the Universidad de Concepción (Chile), with a branch of researchers from MELISA Institute and other international academic centers, made progress in the understanding of molecular mechanisms preventing an effective antitumor immune response in oral cancer; The latter due to the production of chemical mediators that induce an anti-inflammatory regulatory response that favors tumor development through the vitamin D signaling pathway. The study was published in Frontiers in Immunology on May 7, 2021.
